EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
2.1.1.244 | S-adenosyl-L-methionine + Rps25a |
- |
Saccharomyces cerevisiae |
? |
- |
? |
2.1.1.244 | S-adenosyl-L-methionine + Rps25a |
Rps25a and Rps25b differ only at position 104, a threonine residue is present in the former and an alanine residue in the latter |
Saccharomyces cerevisiae |
? |
- |
? |
2.1.1.244 | S-adenosyl-L-methionine + Rps25b |
- |
Saccharomyces cerevisiae |
? |
- |
? |
2.1.1.244 | S-adenosyl-L-methionine + Rps25b |
Rps25a and Rps25b differ only at position 104, a threonine residue is present in the former and an alanine residue in the latter |
Saccharomyces cerevisiae |
? |
- |
? |
2.1.1.244 | S-adenosyl-L-methionine + SET/TAF-I/PHAPII |
only the SETalpha splicing variant is a substrate for NRMT, since it begins with the NRMT consensus in contrast to the beta splicing variant |
Homo sapiens |
S-adenosyl-L-homocysteine + ? |
- |
? |
2.1.1.244 | S-adenosyl-L-methionine + SPKQQLSKY |
synthetic peptide, modified Rps25a/Rps25b-derived peptide |
Saccharomyces cerevisiae |
? |
- |
? |
2.1.1.244 | S-adenosyl-L-methionine + SPKQQLSKY |
synthetic peptide, modified yeast protein Rps25a/Rps25b-derived peptide |
Mus musculus |
? |
- |
? |
2.1.1.244 | S-adenosyl-L-methionine + SPKQQLSKY |
synthetic peptide, modified yeast protein Rps25a/Rps25b-derived peptide |
Homo sapiens |
? |
- |
? |
2.1.1.244 | S-adenosyl-L-methionine + SPKRIAKRRSPPADA |
substrate peptide consisting of the first 15 amino acids of RCC1. NRMT2 V224L is able to significantly decrease the NRMT1 Km with the RCC1 peptide |
Homo sapiens |
? |
- |
? |
2.1.1.244 | S-adenosyl-L-methionine + SSKRAKAKTTKKRP |
substrate peptide consisting of the first 14 amino acids of MYL9 |
Homo sapiens |
? |
- |
? |